Bokf, Na Exelixis, Inc. Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Exelixis, Inc. stock. As of the latest transaction made, Bokf, Na holds 12 shares of EXEL stock, worth $427. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 12 -0.0%

Holding current value

$427

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$20.34 - $23.73 $833 - $972	-41 Reduced 77.36%	12 $0
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $38 - $48	2 Added 3.92%	53 $1,000
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $971 - $1,159	51 New	51 $1,000
Q4 2021 Mar 11, 2022	SELL	$15.84 - $21.88 $398,581 - $550,566	-25,163 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$16.3 - $21.14 $17,261 - $22,387	1,059 Added 4.39%	25,163 $532,000
Q1 2021 Apr 21, 2021	BUY	$20.53 - $25.22 $168,982 - $207,585	8,231 Added 51.86%	24,104 $545,000
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $621,195 - $837,719	-33,779 Reduced 68.03%	15,873 $318,000
Q3 2020 Oct 30, 2020	SELL	$20.67 - $26.94 $277,040 - $361,076	-13,403 Reduced 21.26%	49,652 $1.21 Million
Q2 2020 Aug 12, 2020	SELL	$16.46 - $27.42 $531,789 - $885,885	-32,308 Reduced 33.88%	63,055 $1.5 Million
Q1 2020 May 13, 2020	SELL	$14.46 - $21.8 $423,099 - $637,868	-29,260 Reduced 23.48%	95,363 $1.64 Million
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $223,356 - $278,495	-14,743 Reduced 10.58%	124,623 $2.2 Million
Q3 2019 Nov 13, 2019	SELL	$17.68 - $22.65 $43,811 - $56,126	-2,478 Reduced 1.75%	139,366 $2.47 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $609,564 - $796,974	32,201 Added 29.37%	141,844 $3.03 Million
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $134,632 - $170,076	6,869 Added 6.68%	109,643 $2.61 Million
Q4 2018 Feb 13, 2019	BUY	$13.65 - $21.8 $475,839 - $759,948	34,860 Added 51.33%	102,774 $2.02 Million
Q3 2018 Nov 13, 2018	BUY	$15.87 - $22.4 $30,422 - $42,940	1,917 Added 2.9%	67,914 $1.2 Million
Q2 2018 Aug 13, 2018	BUY	$18.56 - $22.45 $41,704 - $50,445	2,247 Added 3.52%	65,997 $1.42 Million
Q1 2018 May 14, 2018	BUY	$22.15 - $31.89 $1.41 Million - $2.03 Million	63,750 New	63,750 $1.41 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.19 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.04 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$905 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$547 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$408 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account